Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Hunton & Williams LLP | Contract Pharma
Breaking News, Promotions & Moves

Hunton & Williams LLP

Dan L. O’Korn has joined Hunton & Williams’ Raleigh office as a partner with its life science practice, a multidisciplinary group of more than 45 lawyers with patent, FDA, litigation and corporate experience. He joins the firm as part of its commitment to strengthen the firm’s biotechnology law practice in North Carolina, where he will focus on pharmaceutical and biotech transactions and FDA-related regulatory matters.

Mr. O’Korn has more than 13 years of legal experience, the majority of it devoted to the pharmaceutical industry. Most recently, he served as the vice president and general counsel of Xanodyne Pharmaceuticals, a privately owned pharmaceutical company committed to women’s health and pain management. Prior to that, he was senior corporate counsel at AAIPharma, Inc. in Wilmington, NC, where he served as lead attorney on several major product acquisitions and divestitures. Before joining AAIPharma Inc., he worked with Lilly, where he focused on complex product acquisitions and divestitures as well as general commercial transactions.

“Dan O’Korn is an invaluable addition to our firm,” says William S. Patterson, managing partner of the Raleigh office of Hunton & Williams. “The need for sophisticated counsel with life sciences experience continues to grow in the Triangle and elsewhere. Dan’s extensive background both complements our existing capabilities and adds a strong dimension of experience to our client service.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters